Related Experiment Videos
Focal segmental glomerulosclerosis associated with acromegaly
1Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Japan.
Clinical Nephrology
|August 14, 2001
Summary
Acromegaly, a condition of excess growth hormone (GH), is rarely linked to focal segmental glomerulosclerosis (FSGS). This case suggests GH overproduction may contribute to FSGS development, even after treatment.
Area of Science:
- Nephrology
- Endocrinology
Background:
- Focal segmental glomerulosclerosis (FSGS) is a significant cause of kidney disease.
- Acromegaly, characterized by excessive growth hormone (GH) production, is rarely associated with FSGS.
- Experimental rat models suggest a link between GH and FSGS.
Observation:
- A 53-year-old male with a 15-year history of acromegaly presented with moderate proteinuria.
- Renal biopsy confirmed FSGS and glomerular hypertrophy.
- Despite successful pituitary adenoma removal and normalization of GH and IGF-1 levels, proteinuria persisted.
Findings:
- This case highlights a rare instance of FSGS complicating acromegaly in a human patient.
- The findings suggest that GH overproduction may play a role in the pathogenesis of human FSGS.
- Persistent proteinuria after GH normalization indicates potential irreversible kidney damage.
Implications:
- Excessive growth hormone may be a contributing factor to the development of FSGS in susceptible individuals.
- In acromegalic patients with established FSGS, normalizing GH levels might not be sufficient to reverse kidney damage.
- Further research is warranted to elucidate the precise mechanisms linking GH and FSGS and to explore therapeutic strategies.